In this review, we summarized the roles of sex-specific bioactive molecules (estrogens, progesterone, testosterone, FSH, LH, prolactin, leptin, activin, and inhibin) in the immune response to lung cancer and immunotherapy effectiveness. This evidence concerns the gene BRD2 and lung carcinoma.